数据显示，上半年神州控股实现营业收入 78.65 亿元，同比增长 12%；毛利10.33亿元人民币，较去年 同期增长8%，归母净利润 1521 万元，同比大幅增长 41%。报告期内，公司新签约金额达 94.76 亿元， 同比激增 98%；已签未销订单 104.41 亿元，同比增长 27%。 公司管理层指出，数据是 AI 释放效能的核心，场景化能力是当前 AI 赛道竞争关键，因此在强化数据 层能力的同时，结合行业场景优势形成了技术闭环。据悉，神州控股未来还将开放数据能力基座与 AI 工具链，降低赋能门槛、扩大生态影响力。 北京商报讯（记者 陶凤 实习记者 王天逸） 9月11日，北京商报记者获悉，神州控股日前召开了2025年 度中期业绩说明会，管理层就上半年经营成果、技术研发进展、面向核心场景的业务进展，以及生态战 略的推进落实情况进行详细解读，并对投资者关切问题做出回应。 ...

相关事件 基石药业-B(02616.HK)遭非执行董事胡正国减持22.3万股 基石药业-B(02616.HK)授出合共480万份购股 权 减持后，胡正国最新持股数目为247.1万股，持股比例由0.18%下降至0.17%。 格隆汇9月11日丨根据联交所最新权益披露资料显示，2025年9月5日，基石药业-B(02616.HK)遭非执行 董事胡正国在场内以每股均价12.007港元减持22.3万股，涉资约267.8万港元。 ...

Group 1 - Chongqing Machinery and Electric (02722) shares rose over 8%, reaching a new high of 2.04 HKD, with a year-to-date increase of over 160% [1] - OpenAI has reportedly signed an agreement to purchase computing power worth 300 billion USD from Oracle over approximately five years [1] - The China Academy of Information and Communications Technology released a report indicating that China's intelligent computing power is expected to reach 1,037.3 EFLOPS by 2025 and 2,781.9 EFLOPS by 2028 [1] Group 2 - According to Zheshang Securities, diesel generator sets are essential backup power sources for data center power systems, with demand for high-performance and reliable diesel generator sets expected to surge due to the rapid construction of global AI computing centers [1] - Guoyuan International noted that the company's main business profitability is steadily improving, with large-capacity engines experiencing sustained high demand [1] - The company reported a total operating revenue of approximately 4.658 billion RMB for the first half of the year, a year-on-year increase of 9.2%, and a gross profit increase of about 10.4% [1] - The company's net profit attributable to shareholders reached 416 million RMB, a year-on-year increase of 53.8% [1]

消息面上，正力新能公布，公司股份已被调入沪港通及深港通下港股通标的证券名单，自9月8日起生 效。董事会认为，公司被调入沪港通及深港通下港股通标的证券名单，将有助加快扩大公司股东基础及 提高公司股份的交易流通性，并进一步提高公司在资本市场上的声誉及公司的品牌知名度。 值得注意的是，8月18日，零重力飞机工业与正力新能正式签署航空能源系统战略合作协议，由正力新 能配套的锐翔RX1E系列电动固定翼飞机航空电池，随整机获批中国民航局颁发的适航证，正式开启批 量化交付。此次与正力新能的合作将进一步优化锐翔RX1E系列的产品力，标志中国目前唯一可商用的 电动轻型运动类飞机RX1E系列正式进入加速批量化生产时代。 正力新能(03677)再涨超5%，截至发稿，涨5.67%，报11.55港元，成交额1.41亿港元。 ...

Core Viewpoint - Starbucks is in the final stages of selling its stake in the Chinese market, with potential buyers including Boyu Capital, Carlyle Group, EQT, and Sequoia China, aiming to finalize the deal by the end of October [1] Group 1: Stake Sale Details - The sale involves discussions about the proportion of equity Starbucks will retain, with reports suggesting that Starbucks may keep around 30% of the stake while distributing the remaining shares among several buyers [2] - CEO Brian Niccol emphasized the importance of retaining a significant portion of equity to maintain operational control in China [3] Group 2: Operational Flexibility - Starbucks has demonstrated increased operational flexibility in China, including a partnership with Xiaohongshu to enhance community engagement in over 1,800 stores [7] - The company has also adjusted pricing strategies, reducing prices on key products, resulting in significant sales growth, particularly for iced tea and frappuccinos [8][10] Group 3: Competitive Landscape - The competitive environment in the Chinese coffee market is intensifying, with Luckin Coffee reporting a 47.1% year-on-year revenue increase, significantly outpacing Starbucks [11] - Other domestic brands, such as Kudi Coffee, are rapidly expanding, with Kudi surpassing 15,000 stores and achieving profitability [12] - Starbucks reported a 2% year-on-year same-store sales growth, with a decline in average transaction value, highlighting the challenges faced in maintaining market share [12] Group 4: Strategic Importance of Local Partnerships - Finding a partner that understands the Chinese market is crucial for Starbucks' expansion strategy, as indicated by CEO Brian Niccol [13] - The outcome of the stake sale will determine the future operational dynamics of Starbucks in China [14]

智通财经APP获悉，富瑞发布研报称，阿里巴巴-W(09988,BABA.US)公布拟发行32亿美元零息可换股债 券，反映其对前景信心，集资主要用于云端运算及国际商务业务。相较现有现金储备，发行可转换债券 可降低资金成本。其对阿里巴巴的目标价为172港元，美股目标价为178美元。基于阿里巴巴的市值规 模，富瑞估计摊薄影响有限。如近期报告所述，云端运算业务在AI需求驱动下预期维持高速增长，而 快闪店业务将随着用户体验提升释放协同效应。 ...

消息面上，正力新能公布，公司股份已被调入沪港通及深港通下港股通标的证券名单，自9月8日起生 效。董事会认为，公司被调入沪港通及深港通下港股通标的证券名单，将有助加快扩大公司股东基础及 提高公司股份的交易流通性，并进一步提高公司在资本市场上的声誉及公司的品牌知名度。 值得注意的是，8月18日，零重力飞机工业与正力新能正式签署航空能源系统战略合作协议，由正力新 能配套的锐翔RX1E系列电动固定翼飞机航空电池，随整机获批中国民航局颁发的适航证，正式开启批 量化交付。此次与正力新能的合作将进一步优化锐翔RX1E系列的产品力，标志中国目前唯一可商用的 电动轻型运动类飞机RX1E系列正式进入加速批量化生产时代。 智通财经APP获悉，正力新能(03677)再涨超5%，截至发稿，涨5.67%，报11.55港元，成交额1.41亿港 元。 ...

Core Viewpoint - The report from Jefferies indicates that Alibaba-W (09988, BABA.US) plans to issue $3.2 billion in zero-coupon convertible bonds, reflecting confidence in its future prospects, with the funds primarily allocated for cloud computing and international business [1] Group 1 - The issuance of convertible bonds is expected to lower the cost of capital compared to existing cash reserves [1] - Jefferies sets a target price of HKD 172 for Alibaba and USD 178 for its U.S. shares [1] - The dilution impact from the bond issuance is estimated to be limited due to Alibaba's market capitalization [1] Group 2 - The cloud computing business is anticipated to maintain rapid growth driven by AI demand [1] - The pop-up store business is expected to release synergistic effects as user experience improves [1]

智通财经APP获悉，富力地产(02777)跌超4%，截至发稿，跌4.05%，报0.71港元，成交额621.97万港 元。 消息面上，9月10日晚，富力地产公告称，鉴于当前公司的整体经营现状，拟初步为境内公司债券持有 人提供整体境内债券重组方案，包括现金购回、以物抵债、应收账款信托份额抵债、资产信托份额抵 债、股票经济收益权兑付和全额留债长展期等6种选择。据悉，富力此次境内债重组涉及6只债券，未偿 还剩余本金余额逾122亿元。 今年上半年，富力地产实现营业额57.65亿元人民币，同比减少59.43%；公司所有者应占亏损40.46亿 元，同比扩大73.6%。此外，上交所、深交所近日发布的公告显示，富力地产被调出港股通标的名单， 并自9月8日起生效。 ...

智通财经APP获悉，映恩生物-B(09606)午后涨超10%，高见480港元，再创上市新高。截至发稿，涨 10.85%，报480港元，成交额5.79亿港元。 消息面上，映恩生物发布公告，自2025年9月8日起，公司股份将获恒生指数有限公司纳入恒生综合指数 成份股及被调入沪港通下港股通标的名单。公告表示，股份获纳入恒生综合指数及沪港通合资格证券， 代表资本市场对公司表现及价值的高度认同，中国内地合资格投资者从而可以透过上交所直接投资于香 港联交所上市的股份。预期该项纳入将进一步扩大公司的投资者基础，并有望增加股份的交易流通量。 海通国际发布研报称，映恩生物中期间营收12.3亿元，主要由于确认了DB-1418授权Avenzo的首付款 5000万美元以及DB-1303国内权益授权三生制药的首付款 2000万美元。公司期内亏损大幅增加主要来自 以公允价值计量且变动计入当期损益的金融负债公允价值变动。考虑到未来潜在的BD交易里程碑及销 售分成收入，公司目前持有的37.5亿元现金足以支撑未来3~5年的临床及早期研发投入。该行指出，公 司和BioNTech合作的管线稳步推进，早期分子有望展露潜力。 ...